curaleaf holdings - CURLF

CURLF

Close Chg Chg %
2.10 -0.13 -5.97%

Open Market

1.97

-0.13 (5.97%)

Volume: 539.28K

Last Updated:

Nov 21, 2024, 1:24 PM EDT

Company Overview: curaleaf holdings - CURLF

CURLF Key Data

Open

$2.05

Day Range

1.91 - 2.11

52 Week Range

1.64 - 6.40

Market Cap

$1.57B

Shares Outstanding

749.47M

Public Float

455.68M

Beta

1.35

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.27

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.05M

 

CURLF Performance

1 Week
 
-5.63%
 
1 Month
 
-38.56%
 
3 Months
 
-34.81%
 
1 Year
 
-40.48%
 
5 Years
 
-65.93%
 

CURLF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 10
Full Ratings ➔

About curaleaf holdings - CURLF

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

CURLF At a Glance

Curaleaf Holdings, Inc.
420 Lexington Avenue
New York, New York 10170
Phone N/A Revenue 1.35B
Industry Agricultural Commodities/Milling Net Income -281,197,000.00
Sector Process Industries 2023 Sales Growth 0.77%
Fiscal Year-end 12 / 2024 Employees N/A
View SEC Filings

CURLF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 2.247
Price to Book Ratio 2.918
Price to Cash Flow Ratio 40.205
Enterprise Value to EBITDA 16.299
Enterprise Value to Sales 3.084
Total Debt to Enterprise Value 0.264

CURLF Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 21.484
Total Asset Turnover 0.415

CURLF Liquidity

Current Ratio 0.847
Quick Ratio 0.41
Cash Ratio 0.186

CURLF Profitability

Gross Margin 35.471
Operating Margin 3.184
Pretax Margin -9.235
Net Margin -20.882
Return on Assets -7.077
Return on Equity -19.724
Return on Total Capital -10.695
Return on Invested Capital -10.385

CURLF Capital Structure

Total Debt to Total Equity 104.528
Total Debt to Total Capital 51.107
Total Debt to Total Assets 35.466
Long-Term Debt to Equity 97.801
Long-Term Debt to Total Capital 47.818
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Curaleaf Holdings - CURLF

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
626.64M 1.21B 1.34B 1.35B
Sales Growth
+183.52% +93.04% +10.47% +0.77%
Cost of Goods Sold (COGS) incl D&A
529.41M 1.08B 873.16M 868.97M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
88.47M 132.64M 176.47M 211.91M
Depreciation
- - - 90.83M
-
Amortization of Intangibles
- - - 121.08M
-
COGS Growth
+153.50% +104.66% -19.41% -0.48%
Gross Income
97.23M 126.19M 463.18M 477.67M
Gross Income Growth
+698.64% +29.79% +267.05% +3.13%
Gross Profit Margin
+15.52% +10.43% +34.66% +35.47%
2020 2021 2022 2023 5-year trend
SG&A Expense
258.15M 415.74M 475.56M 434.78M
Research & Development
- - - -
-
Other SG&A
258.15M 415.74M 475.56M 434.78M
SGA Growth
+87.57% +61.04% +14.39% -8.57%
Other Operating Expense
- - - -
-
Unusual Expense
(224.61M) (450.61M) 144.26M 65.01M
EBIT after Unusual Expense
63.68M 161.06M (156.63M) (22.13M)
Non Operating Income/Expense
27.36M (6.00M) 23.53M (1.86M)
Non-Operating Interest Income
6.48M 629.00K 137.00K 23.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
69.00M 90.26M 93.33M 100.38M
Interest Expense Growth
+178.76% +30.81% +3.40% +7.56%
Gross Interest Expense
69.00M 90.26M 93.33M 100.38M
Interest Capitalized
- - - -
-
Pretax Income
22.04M 64.80M (226.43M) (124.37M)
Pretax Income Growth
+148.14% +193.95% -449.45% +45.08%
Pretax Margin
+3.52% +5.36% -16.94% -9.24%
Income Tax
83.37M 173.93M 150.50M 114.59M
Income Tax - Current - Domestic
75.83M 154.82M 176.49M 143.90M
Income Tax - Current - Foreign
- - (304.00K) 123.00K
-
Income Tax - Deferred - Domestic
7.54M 19.11M (23.30M) (29.83M)
Income Tax - Deferred - Foreign
- - (2.39M) 394.00K
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(61.33M) (109.13M) (376.93M) (238.96M)
Minority Interest Expense
407.00K (7.40M) (6.83M) (9.14M)
Net Income
(61.74M) (101.73M) (370.10M) (229.82M)
Net Income Growth
+8.19% -64.79% -263.80% +37.90%
Net Margin Growth
-9.85% -8.41% -27.69% -17.07%
Extraordinaries & Discontinued Operations
- - - (51.38M)
-
Discontinued Operations
- - - (51.38M)
-
Net Income After Extraordinaries
(61.74M) (101.73M) (370.10M) (281.20M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(61.74M) (101.73M) (370.10M) (281.20M)
EPS (Basic)
-0.1108 -0.1456 -0.5204 -0.3883
EPS (Basic) Growth
+23.74% -31.41% -257.42% +25.38%
Basic Shares Outstanding
557.19M 698.76M 711.16M 724.12M
EPS (Diluted)
-0.1108 -0.1456 -0.5204 -0.3883
EPS (Diluted) Growth
+23.74% -31.41% -257.42% +25.38%
Diluted Shares Outstanding
557.19M 698.76M 711.16M 724.12M
EBITDA
(72.46M) (156.90M) 164.10M 254.80M
EBITDA Growth
+17.89% -116.54% +204.59% +55.27%
EBITDA Margin
-11.56% -12.97% +12.28% +18.92%

Snapshot

Average Recommendation BUY Average Target Price 4.598
Number of Ratings 10 Current Quarters Estimate -0.067
FY Report Date 12 / 2024 Current Year's Estimate -0.242
Last Quarter’s Earnings -0.07 Median PE on CY Estimate N/A
Year Ago Earnings -0.32 Next Fiscal Year Estimate -0.186
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 4 8 7
Mean Estimate -0.07 -0.06 -0.24 -0.19
High Estimates -0.04 -0.06 -0.16 -0.05
Low Estimate -0.08 -0.07 -0.27 -0.25
Coefficient of Variance -23.48 -4.48 -15.94 -37.98

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 9
OVERWEIGHT 0 1 1
HOLD 2 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Curaleaf Holdings in the News